157 related articles for article (PubMed ID: 36756095)
1. Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes.
Loganathan A; Bharadwaj R; Srinivasan A; Scott JX
South Asian J Cancer; 2022 Oct; 11(4):353-360. PubMed ID: 36756095
[TBL] [Abstract][Full Text] [Related]
2. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
[TBL] [Abstract][Full Text] [Related]
3. The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL.
Soszynska K; Mucha B; Debski R; Skonieczka K; Duszenko E; Koltan A; Wysocki M; Haus O
Ann Hematol; 2008 Dec; 87(12):991-1002. PubMed ID: 18633615
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetics in childhood acute lymphoblastic leukemia: a hospital-based observational study.
Pandita A; Harish R; Digra SK; Raina A; Sharma AA; Koul A
Clin Med Insights Oncol; 2015; 9():39-42. PubMed ID: 25861237
[TBL] [Abstract][Full Text] [Related]
5. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong.
Tsang KS; Li CK; Chik KW; Shing MM; Tsoi WC; Ng MH; Lau TT; Leung Y; Yuen PM
Am J Hematol; 2001 Oct; 68(2):91-8. PubMed ID: 11559948
[TBL] [Abstract][Full Text] [Related]
6. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
[TBL] [Abstract][Full Text] [Related]
7. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
[TBL] [Abstract][Full Text] [Related]
8. [A comparison of minimal residual disease in children with acute lymphoblastic leukemia of different genetic abnormalities].
Huang SY; Jia YP; Liu GL; Zhang LP; Lu AD; Wang B
Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):494-8. PubMed ID: 24856999
[TBL] [Abstract][Full Text] [Related]
9. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed between 2001 and 2014.
Yin MM; Wu RC; Gao J; Hu SY; Liu XM; Zhu XF; Shen SH; Tang JY; Chen J; Hu Q
Curr Med Sci; 2022 Feb; 42(1):201-209. PubMed ID: 34874488
[TBL] [Abstract][Full Text] [Related]
11. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
[TBL] [Abstract][Full Text] [Related]
12. Induction Chemotherapy Response in Childhood Acute Lymphoblastic Leukaemia and its Correlation with Cytogenetic and Molecular Features.
Rana NA; Mahmood A; Robert HM; Zahir S; Ali I; Riaz S
J Coll Physicians Surg Pak; 2022 Nov; 32(11):1430-1434. PubMed ID: 36377010
[TBL] [Abstract][Full Text] [Related]
13. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Cazzaniga G; De Lorenzo P; Alten J; Röttgers S; Hancock J; Saha V; Castor A; Madsen HO; Gandemer V; Cavé H; Leoni V; Köhler R; Ferrari GM; Bleckmann K; Pieters R; van der Velden V; Stary J; Zuna J; Escherich G; Stadt UZ; Aricò M; Conter V; Schrappe M; Valsecchi MG; Biondi A
Haematologica; 2018 Jan; 103(1):107-115. PubMed ID: 29079599
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
16. Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes.
Huang YJ; Coustan-Smith E; Kao HW; Liu HC; Chen SH; Hsiao CC; Yang CP; Jaing TH; Yeh TC; Kuo MC; Lai CL; Chang CH; Campana D; Liang DC; Shih LY
J Formos Med Assoc; 2017 Oct; 116(10):774-781. PubMed ID: 28063722
[TBL] [Abstract][Full Text] [Related]
17. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.
van Dongen JJ; Macintyre EA; Gabert JA; Delabesse E; Rossi V; Saglio G; Gottardi E; Rambaldi A; Dotti G; Griesinger F; Parreira A; Gameiro P; Diáz MG; Malec M; Langerak AW; San Miguel JF; Biondi A
Leukemia; 1999 Dec; 13(12):1901-28. PubMed ID: 10602411
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008.
Morishige S; Miyamoto T; Eto T; Uchida N; Kamimura T; Miyazaki Y; Ogawa R; Okumura H; Fujisak T; Iwasaki H; Kawano N; Wake A; Ohta T; Takamatsu Y; Kurokawa T; Ito Y; Maeda T; Akashi K; Nagafuji K
Int J Hematol; 2021 Jun; 113(6):815-822. PubMed ID: 33725318
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Two Quantitative PCR-Based Assays for Detection of Minimal Residual Disease in B-Precursor Acute Lymphoblastic Leukemia Harboring Three Major Fusion Transcripts.
Huang YJ; Kuo MC; Jaing TH; Liu HC; Yeh TC; Chen SH; Lin TL; Yang CP; Wang PN; Sheen JM; Chang TK; Chang CH; Hu SF; Huang TY; Wang SC; Wu KH; Chiou SS; Hsiao CC; Shih LY
J Mol Diagn; 2021 Oct; 23(10):1373-1379. PubMed ID: 34325057
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease.
Issa GC; Kantarjian HM; Yin CC; Qiao W; Ravandi F; Thomas D; Short NJ; Sasaki K; Garcia-Manero G; Kadia TM; Cortes JE; Daver N; Borthakur G; Jain N; Konopleva M; Khouri I; Kebriaei P; Champlin RE; Pierce S; O'Brien SM; Jabbour E
Cancer; 2017 Feb; 123(3):459-467. PubMed ID: 27696391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
